What is the recommended dose adjustment for Ceftazidime (Ceftazidime) in patients with impaired renal function (Renal Impairment)?

Ceftazidime Renal Dose Adjustment

In patients with renal impairment (GFR <50 mL/min), reduce ceftazidime dosing frequency while maintaining the dose amount: give 1 gram every 12 hours for CrCl 31-50 mL/min, every 24 hours for CrCl 16-30 mL/min, 500 mg every 24 hours for CrCl 6-15 mL/min, and 500 mg every 48 hours for CrCl <5 mL/min. 1

Initial Loading Dose

• Administer a full 1 gram loading dose regardless of renal function to rapidly achieve therapeutic concentrations, even in patients with severe renal insufficiency 1
• This loading dose should not be reduced based on creatinine clearance, as it is essential for achieving initial bactericidal activity 1

Maintenance Dosing by Renal Function

The FDA-approved dosing schedule based on creatinine clearance is:

• CrCl 50-31 mL/min: 1 gram every 12 hours 1
• CrCl 30-16 mL/min: 1 gram every 24 hours 1
• CrCl 15-6 mL/min: 500 mg every 24 hours 1
• CrCl <5 mL/min: 500 mg every 48 hours 1

Important caveat: If the standard dose for the infection being treated (from Table 3 in the label) is lower than the renal-adjusted dose, use the lower dose 1

Estimating Creatinine Clearance

When only serum creatinine is available, use the Cockcroft-Gault equation 1:

• Males: CrCl (mL/min) = [Weight (kg) × (140 - age)] / [72 × serum creatinine (mg/dL)] 1
• Females: 0.85 × male value 1
• Ensure serum creatinine represents steady-state renal function 1

Severe Infections in Renal Impairment

• For patients with severe infections who would normally receive 6 grams daily but have renal insufficiency, increase the unit dose by 50% or increase dosing frequency beyond the standard renal adjustments 1
• Monitor therapeutic drug levels, infection severity, and pathogen susceptibility to guide further dosing 1

Hemodialysis Patients

• Give 1 gram loading dose, followed by 1 gram after each hemodialysis session 1
• Administer the dose after dialysis to avoid premature drug removal and facilitate directly observed therapy 1
• During a 6-8 hour hemodialysis session, approximately 88% of ceftazidime is removed, with a dialysis half-life of 2.8 hours 2

Peritoneal Dialysis Patients

• Loading dose: 1 gram IV 1
• Maintenance: 500 mg every 24 hours IV 1
• Alternative intraperitoneal route: Add 250 mg per 2 liters of dialysis fluid 1
• For chronic ambulatory peritoneal dialysis: 10 mg/kg loading dose followed by 5 mg/kg into each dialysis exchange 3

Pharmacokinetic Rationale

• Ceftazidime is almost entirely eliminated by glomerular filtration (83.6% excreted unchanged in urine), making dose adjustment essential in renal impairment 2
• The elimination half-life increases from 1.5-2 hours in normal renal function to approximately 25 hours in severe uremia 2, 3
• Protein binding is low (typically <10%), and the drug is not metabolized, so hepatic dysfunction requires no adjustment 1, 4
• The volume of distribution remains stable across all degrees of renal impairment at approximately 0.23 L/kg 2

Continuous Renal Replacement Therapy (CRRT)

• Ceftazidime is effectively removed by CRRT with sieving coefficients of approximately 0.93 5
• For anuric patients on CRRT: Standard renal dosing may result in excessive trough levels and increased nephrotoxicity risk 5
• For non-anuric patients on CRRT: Higher doses may be needed as residual renal function contributes significantly to clearance 5
• Consider therapeutic drug monitoring in CRRT patients to optimize dosing 5

Monitoring Requirements

• Baseline: Serum creatinine and estimated GFR 1
• Ongoing: Monitor renal function regularly, as ceftazidime can rarely cause nephrotoxicity (though less than aminoglycosides) 4
• Be vigilant for neurological symptoms (confusion, encephalopathy, myoclonus, seizures) in patients with severe renal impairment, as beta-lactams can cause neurotoxicity even with appropriate dose adjustments 6

Pediatric Renal Dosing

• Adjust creatinine clearance for body surface area or lean body mass 1
• Reduce dosing frequency proportionally to the degree of renal insufficiency, similar to adults 1
• Standard pediatric dose is 30-50 mg/kg every 8 hours (maximum 6 grams/day), which should be adjusted based on calculated pediatric creatinine clearance 1

Critical Pitfalls to Avoid

• Do not reduce the loading dose in renal impairment—this leads to subtherapeutic initial concentrations 1
• Do not use every 6-hour dosing in CRRT patients, as this may cause unnecessarily high trough levels and increase nephrotoxicity risk 5
• Avoid administering before hemodialysis, as the drug will be removed before achieving therapeutic effect 1
• Do not forget to adjust for actual body weight when using Cockcroft-Gault equation, especially in obese or cachectic patients 1